| 19th Apr 2017 4:27 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2017 4:14 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2017 4:04 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2017 1:32 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2017 1:27 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2017 1:21 pm |
RNS |
Director/PDMR Shareholding |
| 18th Apr 2017 4:13 pm |
RNS |
Director/PDMR Shareholding |
| 18th Apr 2017 9:16 am |
RNS |
GSK vaccine submission for shingles in Japan |
| 11th Apr 2017 5:26 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2017 12:02 pm |
RNS |
Change to financial reporting framework |
| 3rd Apr 2017 11:26 am |
RNS |
Total Voting Rights |
| 31st Mar 2017 11:04 am |
RNS |
Phase 3 study start of mepolizumab in severe HES |
| 30th Mar 2017 1:00 pm |
RNS |
Notice of AGM |
| 23rd Mar 2017 4:55 pm |
RNS |
Director/PDMR Shareholding |
| 21st Mar 2017 12:19 pm |
RNS |
Director/PDMR Shareholding |
| 20th Mar 2017 7:00 am |
RNS |
GSK 2016 Form 20F |
| 16th Mar 2017 4:13 pm |
RNS |
Director/PDMR Shareholding |
| 15th Mar 2017 5:07 pm |
RNS |
Director/PDMR Shareholding |
| 14th Mar 2017 1:00 pm |
RNS |
Publication of 2016 Annual Financial Report |
| 10th Mar 2017 4:10 pm |
RNS |
Director/PDMR Shareholding |
| 8th Mar 2017 4:26 pm |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2017 4:51 pm |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2017 2:49 pm |
RNS |
GSK's MUSCA study results on Nucala (mepolizumab) |
| 1st Mar 2017 10:06 am |
RNS |
Total Voting Rights |
| 23rd Feb 2017 3:07 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2017 2:57 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2017 9:59 am |
RNS |
Positive results for Relvar Ellipta Lung Study |
| 22nd Feb 2017 1:58 pm |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2017 5:14 pm |
RNS |
Director/PDMR Shareholding |
| 20th Feb 2017 3:55 pm |
RNS |
Director/PDMR Shareholding |
| 20th Feb 2017 2:12 pm |
RNS |
Director/PDMR Shareholding |
| 17th Feb 2017 3:58 pm |
RNS |
Director/PDMR Shareholding |
| 17th Feb 2017 3:57 pm |
RNS |
Director/PDMR Shareholding |
| 17th Feb 2017 3:55 pm |
RNS |
Director/PDMR Shareholding |
| 15th Feb 2017 5:15 pm |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2017 12:43 pm |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2017 9:49 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2017 7:00 am |
RNS |
ViiV Phase III results Dolutegravir & Rilpivirine |
| 13th Feb 2017 5:04 pm |
RNS |
Director/PDMR Shareholding |
| 10th Feb 2017 3:47 pm |
RNS |
Director/PDMR Shareholding |
